Pharmacogenetics as a Way for Personalizing Diuretic Therapy: Focus on Torasemide
Optimizing diuretic therapy in patients with chronic heart failure is a complicated problem with many unresolved questions. Diuretics take an important place in the treatment of heart failure, which are used in almost 80% of cases. Currently, there are not enough clinical studies, which comparative...
Main Authors: | N. M. Gafurova, E. V. Shikh, O. D. Ostroumova |
---|---|
Format: | Article |
Language: | English |
Published: |
Столичная издательская компания
2021-03-01
|
Series: | Рациональная фармакотерапия в кардиологии |
Subjects: | |
Online Access: | https://www.rpcardio.online/jour/article/view/2396 |
Similar Items
-
Loop diuretics in the treatment of edema: torasemide potentials
by: V V Fomin, et al.
Published: (2008-06-01) -
Diuretics in arterial hypertension: a focus on torasemide
by: G A Baryshnikova, et al.
Published: (2012-12-01) -
Current Clinical and Pharmacological Approaches to the Prescription of Loop Diuretics in Patients with Chronic Heart Failure
by: N. M. Gafurova, et al.
Published: (2020-09-01) -
The potential toxicity of loop diuretics in patients with cardiovascular complications
by: Grzegorz Liczner, et al.
Published: (2018-12-01) -
Loop diuretics in the treatment of hypertension and edema syndrome
by: A A Kirichenko
Published: (2016-03-01)